Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$530M |
| 2 |
AbbVie
ABBV
|
+$429M |
| 3 |
Boston Scientific
BSX
|
+$292M |
| 4 |
Snap
SNAP
|
+$241M |
| 5 |
Royalty Pharma
RPRX
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$327M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$295M |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$294M |
| 4 |
Sysco
SYY
|
+$209M |
| 5 |
Shopify
SHOP
|
+$176M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.65% |
| 2 | Healthcare | 19.7% |
| 3 | Consumer Discretionary | 10.81% |
| 4 | Financials | 9.9% |
| 5 | Communication Services | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Eastman Chemical
EMN
$7.72B
| $2.47M | ﹤0.01% |
35,479
-40
| -0.1% | -$2.52K |
|
|
EPIX
1002
DELISTED
ESSA Pharma
EPIX
| $2.46M | ﹤0.01% |
401,596
+202,797
| +102% | +$962K |
|
1003
Loews
L
$24.6B
| $2.45M | ﹤0.01% |
71,345
+1,976
| +3% | +$66.6K |
|
1004
State Street Materials Select Sector SPDR ETF
XLB
$8.77B
| $2.43M | ﹤0.01% |
+86,362
| New | +$2.27M |
|
|
BLU
1005
DELISTED
BELLUS Health Inc.
BLU
| $2.4M | ﹤0.01% |
232,730
+93,937
| +68% | +$952K |
|
1006
Interactive Brokers
IBKR
$39.2B
| $2.39M | ﹤0.01% |
+229,056
| New | +$2.39M |
|
1007
Teva Pharmaceuticals
TEVA
$40.9B
| $2.36M | ﹤0.01% |
191,277
+63,790
| +50% | +$721K |
|
|
AZPN
1008
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $2.31M | ﹤0.01% |
22,302
-25,846
| -54% | -$2.68M |
|
1009
Raymond James Financial
RJF
$33.8B
| $2.29M | ﹤0.01% |
49,929
-906
| -2% | -$40.8K |
|
1010
National Beverage
FIZZ
$3.03B
| $2.29M | ﹤0.01% |
75,014
+11,426
| +18% | +$308K |
|
1011
Universal Display
OLED
$3.78B
| $2.27M | ﹤0.01% |
15,137
-103,598
| -87% | -$15.2M |
|
1012
AMN Healthcare
AMN
$1.36B
| $2.26M | ﹤0.01% |
49,882
+21,366
| +75% | +$1.02M |
|
1013
Knight Transportation
KNX
$11.5B
| $2.25M | ﹤0.01% |
54,068
+36,545
| +209% | +$1.39M |
|
|
STOR
1014
DELISTED
STORE Capital Corporation
STOR
| $2.22M | ﹤0.01% |
93,311
-280,795
| -75% | -$5.62M |
|
1015
Credicorp
BAP
$31B
| $2.19M | ﹤0.01% |
16,410
-60,940
| -79% | -$8.68M |
|
1016
Baker Hughes
BKR
$59.9B
| $2.19M | ﹤0.01% |
141,985
+1,419
| +1% | +$20.8K |
|
1017
Advance Auto Parts
AAP
$3.54B
| $2.18M | ﹤0.01% |
15,277
+1,750
| +13% | +$222K |
|
1018
BlackBerry
BB
$4.75B
| $2.15M | ﹤0.01% |
441,314
+366,408
| +489% | +$1.66M |
|
1019
Open Text
OTEX
$6.35B
| $2.13M | ﹤0.01% |
50,295
+5,229
| +12% | +$207K |
|
1020
Houlihan Lokey
HLI
$9.9B
| $2.11M | ﹤0.01% |
37,899
+33,823
| +830% | +$1.97M |
|
|
TRQ
1021
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $2.05M | ﹤0.01% |
+281,879
| New | +$1.66M |
|
|
EMBJ
1022
Embraer S.A. ADS
EMBJ
$12.2B
| $2.05M | ﹤0.01% |
343,430
| – | – |
|
1023
Vornado Realty Trust
VNO
$7.78B
| $2.05M | ﹤0.01% |
53,715
-6,203
| -10% | -$241K |
|
1024
NexGen Energy
NXE
$6B
| $2.05M | ﹤0.01% |
+1,578,227
| New | +$2.02M |
|
1025
Watsco Inc
WSO
$12.8B
| $2.02M | ﹤0.01% |
11,366
+7,932
| +231% | +$1.31M |
|
Similar funds
Janus Henderson Group's Q2 2020 Portfolio in Review
As of Q2 2020, Janus Henderson Group held 1,423 positions worth $178B, up 23% from $145B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2020 filing shows 132 new, 511 increased, 643 reduced and 125 closed positions. Its largest new stake was Royalty Pharma: 4,507,138 shares worth $219M. The largest sale was Boeing, an estimated $327M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2020 buy was Royalty Pharma: 4,507,138 shares worth $219M.
- Janus Henderson Group added most to T-Mobile US in Q2 2020, an estimated $530M increase.
- Janus Henderson Group's biggest Q2 2020 reduction was Boeing, cutting an estimated $327M.
- Janus Henderson Group fully exited Allergan plc in Q2 2020, selling an estimated $128M.
- Janus Henderson Group's ten largest holdings make up 23% of its $178B portfolio in Q2 2020.
- Janus Henderson Group opened 132 new positions and closed 125 in Q2 2020.
- Janus Henderson Group's portfolio value rose 23% quarter-over-quarter to $178B.
Based on Janus Henderson Group's 13F filing for Q2 2020, filed 14 Aug 2020.